Provided By GlobeNewswire
Last update: Mar 8, 2024
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy.
NASDAQ:LFWD (10/13/2025, 4:04:12 PM)
0.75
+0.01 (+1.35%)
Find more stocks in the Stock Screener